Full Text View
Tabular View
No Study Results Posted
Related Studies
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
This study has been completed.
Study NCT00320619   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: April 28, 2006   Last Updated: March 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Scoliosis
Kyphosis
Lordosis
Spondylitis
Spinal Stenosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Infectious
Infection
Musculoskeletal Diseases
Spinal Curvatures
Spinal Diseases
Interventions listed in this trial
Epsilon-Aminocaproic Acid (EACA)
Placebo
Additional drug interventions recognized in this trial
6-Aminocaproic Acid
More general drug interventions related to this trial
Antifibrinolytic Agents
Coagulants
Fibrin Modulating Agents
Hematologic Agents
Hemostatics
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services